Pegloticase
Horizon Therapeutics
['methotrexate']
john botson presents 12-month data from the mirror rct combining methotrexate or placebo with #pegloticase in patients with uncontrolled #gout; 60% of patients on combo tx continue treatement at 12 months vs 31% on placebo, with less anti-peg antibodies. #acr22 plenary 
The #LancetRheumatology is a clinical #rheumatology journal publishing innovative & practice-changing research & opinion across all #rheumatic & #MSK disorders